China Cord Blood Corporation(CO)- NYSE
  • Aug. 6, 2015, 8:27 AM
    • Thinly traded micro cap China Cord Blood (NYSE:CO) is up 26% premarket on increased volume in response to its announcement that it received a non-binding acquisition proposal letter from Nanjing Xinjiekou Department Store Co., Ltd. offering to buy the firm at a price no lower than RMB6.0B ($960M), to be paid in cash or a combination of cash and stock.
    • The special committee of the company's board of directors will carefully assess the proposal.
    | Aug. 6, 2015, 8:27 AM | 4 Comments
Company Description
China Cord Blood Corp. engages in the provision of cord blood banking services. It provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies such as cord blood transplants.... More
Sector: Healthcare
Industry: Medical Laboratories & Research
Country: United States